Literature DB >> 22575241

Prophylaxis for adults with haemophilia: one size does not fit all.

Kathelijn Fischer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22575241      PMCID： PMC3320775          DOI： 10.2450/2012.0174-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  32 in total

1.  A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A.

Authors:  Kathelijn Fischer; Maurice E Pouw; Daniel Lewandowski; Mart P Janssen; H Marijke van den Berg; Ben A van Hout
Journal:  Haematologica       Date:  2011-01-27       Impact factor: 9.941

2.  Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized.

Authors:  J Astermark; P Petrini; L Tengborn; S Schulman; R Ljung; E Berntorp
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

3.  Platelets significantly modify procoagulant activities in haemophilia A.

Authors:  U Wartiovaara-Kautto; L Joutsi-Korhonen; S Ilveskero; E Armstrong; R Lassila
Journal:  Haemophilia       Date:  2011-06-20       Impact factor: 4.287

4.  A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).

Authors:  A Gringeri; B Lundin; S von Mackensen; L Mantovani; P M Mannucci
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

5.  Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials.

Authors:  K Fischer; P Collins; S Björkman; V Blanchette; M Oh; S Fritsch; P Schroth; G Spotts; B Ewenstein
Journal:  Haemophilia       Date:  2011-02-07       Impact factor: 4.287

6.  Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels.

Authors:  I E M den Uijl; K Fischer; J G Van Der Bom; D E Grobbee; F R Rosendaal; I Plug
Journal:  Haemophilia       Date:  2010-09-02       Impact factor: 4.287

7.  Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A.

Authors:  P W Collins; V S Blanchette; K Fischer; S Björkman; M Oh; S Fritsch; P Schroth; G Spotts; J Astermark; B Ewenstein
Journal:  J Thromb Haemost       Date:  2008-12-20       Impact factor: 5.824

8.  Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices.

Authors:  C E Walsh; L A Valentino
Journal:  Haemophilia       Date:  2009-06-01       Impact factor: 4.287

9.  Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study.

Authors:  P Collins; A Faradji; M Morfini; M M Enriquez; L Schwartz
Journal:  J Thromb Haemost       Date:  2009-10-11       Impact factor: 5.824

10.  Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.

Authors:  E Santagostino; M E Mancuso; A Tripodi; V Chantarangkul; M Clerici; I Garagiola; P M Mannucci
Journal:  J Thromb Haemost       Date:  2009-01-21       Impact factor: 5.824
View more
  11 in total

1.  Prophylaxis for adults with haemophilia: towards a personalised approach?

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2012-02-13       Impact factor: 3.443

Review 2.  Present and future challenges in the treatment of haemophilia: the patient's perspective.

Authors:  Romano Arcieri; Angelo C Molinari; Stefania Farace; Giuseppe Mazza; Alberto Garnero; Gabriele Calizzani; Paola Giordano; Emily Oliovecchio; Lorenzo Mantovani; Lamberto Manzoli; Paul Giangrande
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

3.  Target of prophylaxis in severe haemophilia: more than factor levels.

Authors:  Antonio Coppola; Massimo Franchini
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

4.  Intermediate Dose Prophylaxis in Adults with Haemophilia: A Clinical Audit from a Resource Limited Setting.

Authors:  Remya Sudevan; Aswathy Ashok Beenakumari; Rema Ganapathy; Manoj Unni; Geeta Vidyadharan; Neeraj Sidharthan
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-18       Impact factor: 0.900

Review 5.  Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX.

Authors:  Angiola Rocino; Massimo Franchini; Antonio Coppola
Journal:  J Clin Med       Date:  2017-04-17       Impact factor: 4.241

6.  Persons With Hemophilia of Generation Y and Their Relatives Attitudes and Expectations From Treatment.

Authors:  Bulent Zulfikar; Basak Koc; Irmak Gumustas; Haluk Zulfikar
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

7.  Adherence to prophylaxis in adolescents and young adults with severe haemophilia: a qualitative study with healthcare professionals.

Authors:  S van Os; N Ryder; D P Hart; N Troop
Journal:  Health Psychol Behav Med       Date:  2020-01-28

Review 8.  Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review.

Authors:  Jing Sun; Xuan Zhou; Nan Hu
Journal:  Orphanet J Rare Dis       Date:  2021-06-26       Impact factor: 4.123

9.  Lack of seasonal variation in bleeding and patient-assessed pain patterns in patients with haemophilia B receiving on-demand therapy.

Authors:  F Shafer; L Smith; N Vendetti; P Rendo; M Carr
Journal:  Haemophilia       Date:  2013-11-29       Impact factor: 4.287

10.  Understanding patient preferences and willingness to pay for hemophilia therapies.

Authors:  Shraddha S Chaugule; Joel W Hay; Guy Young
Journal:  Patient Prefer Adherence       Date:  2015-11-11       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.